The global Gaprin market was valued at US$ 48.43 million in 2022 and is anticipated to reach US$ 589.55 million by 2029, witnessing a CAGR of 42.70% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Gaprin is a complete microbiological protein derived from inactivated cells of non-pathogenic methanotroph..